Compare KNSL & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | KNSL | BIRK |
|---|---|---|
| Founded | 2009 | 1774 |
| Country | United States | United Kingdom |
| Employees | 720 | N/A |
| Industry | Property-Casualty Insurers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 7.9B |
| IPO Year | 2016 | 2023 |
| Metric | KNSL | BIRK |
|---|---|---|
| Price | $391.79 | $41.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $453.33 | $62.69 |
| AVG Volume (30 Days) | 260.7K | ★ 2.5M |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.25% | N/A |
| EPS Growth | ★ 21.77 | N/A |
| EPS | ★ 21.65 | N/A |
| Revenue | ★ $1,873,987,000.00 | N/A |
| Revenue This Year | $7.10 | $13.71 |
| Revenue Next Year | $9.27 | $13.88 |
| P/E Ratio | $18.31 | ★ $17.48 |
| Revenue Growth | ★ 18.04 | N/A |
| 52 Week Low | $341.06 | $36.45 |
| 52 Week High | $512.76 | $57.39 |
| Indicator | KNSL | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 51.70 | 54.31 |
| Support Level | $378.10 | $40.55 |
| Resistance Level | $412.11 | $42.09 |
| Average True Range (ATR) | 14.04 | 1.74 |
| MACD | 1.28 | 0.32 |
| Stochastic Oscillator | 69.40 | 71.96 |
Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.